Related references
Note: Only part of the references are listed.RAD51: Beyond the break
Isabel E. Wassing et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
MYC as a target for cancer treatment
Michael J. Duffy et al.
CANCER TREATMENT REVIEWS (2021)
mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression
Ning Kon et al.
GENES & DEVELOPMENT (2021)
Revisiting prostate cancer metabolism: From metabolites to disease and therapy
Henrique J. Cardoso et al.
MEDICINAL RESEARCH REVIEWS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway
Yong-Qiang Hua et al.
LIFE SCIENCES (2021)
Unraveling the Molecular Tumor-Promoting Regulation of Cofilin-1 in Pancreatic Cancer
Silke D. Werle et al.
CANCERS (2021)
LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway
Ming Xu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis
Jian-Yu Yang et al.
MOLECULAR ONCOLOGY (2021)
Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth
Makoto Kawatani et al.
ACS CHEMICAL BIOLOGY (2021)
Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis
Zhong-Bo Zhang et al.
Aging-US (2021)
MicroRNA-202 suppresses glycolysis of pancreatic cancer by targeting hexokinase 2
Shuang-Jia Wang et al.
JOURNAL OF CANCER (2021)
Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1
Shuyu Zhai et al.
ONCOGENE (2021)
Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer
Kyung Chan Park et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
The enhancement of glycolysis regulates pancreatic cancer metastasis
Jinshou Yang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis
Peiwei Huangyang et al.
CELL METABOLISM (2020)
TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis
Rongkun Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine
Shangnan Dai et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Carcinogenic roles and therapeutic effects of EZH2 in gynecological cancers
Zhong Wan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: role of pyruvate kinase-M2 (PKM2)
Andrew D. James et al.
BRITISH JOURNAL OF CANCER (2020)
KAT2A succinyltransferase activity-mediated 14-3-3 zeta upregulation promotes beta-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells
Yingying Tong et al.
CANCER LETTERS (2020)
Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2
Shu-Heng Jiang et al.
FASEB JOURNAL (2020)
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
B. Pajak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
Prasenjit Dey et al.
CANCER DISCOVERY (2020)
Metabolic Alterations in Pancreatic Cancer Progression
Enza Vernucci et al.
CANCERS (2020)
FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway
Xin Zhang et al.
AGING-US (2020)
Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
Zhihong Xu et al.
BRITISH JOURNAL OF CANCER (2020)
Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
Daniel Masso-Valles et al.
CELLS (2020)
MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer
Zhi-qiang Ye et al.
DISEASE MARKERS (2020)
The role of microRNA in cisplatin resistance or sensitivity
Shanshan Wang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer
Yun Xi et al.
CANCER LETTERS (2020)
Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p
Minglei Ma et al.
CELL CYCLE (2020)
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism
Shuang Nie et al.
FRONTIERS IN ONCOLOGY (2020)
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Jiao Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer
Min Xia et al.
LIFE SCIENCES (2020)
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis
Mei-Juan Tu et al.
MOLECULAR PHARMACOLOGY (2020)
The Warburg Effect 97 Years after Its Discovery
Rosa Maria Pascale et al.
CANCERS (2020)
LncRNA-BLACAT1 Facilitates Proliferation, Migration and Aerobic Glycolysis of Pancreatic Cancer Cells by Repressing CDKN1C via EZH2-Induced H3K27me3
Xin Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications
Lidong Cao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
Vikrant Rai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Intracellular Transport in Cancer Metabolic Reprogramming
Marte Sneeggen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Upregulation of LncRNA PVT1 Facilitates Pancreatic Ductal Adenocarcinoma Cell Progression and Glycolysis by Regulating MiR-519d-3p and HIF-1A
Junwei Sun et al.
JOURNAL OF CANCER (2020)
Metabolic reprogramming in triple-negative breast cancer
Zhanyu Wang et al.
CANCER BIOLOGY & MEDICINE (2020)
Fructose 1,6-bisphosphatase: getting the message across
David J. Timson
BIOSCIENCE REPORTS (2019)
UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer
Qiangsheng Hu et al.
CANCER LETTERS (2019)
PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
Yi Qin et al.
CELL COMMUNICATION AND SIGNALING (2019)
Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration
Brunella Costanza et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
Peter Vaupel et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
Ramesh K. Ramanathan et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1
Ying Yang et al.
NATURE COMMUNICATIONS (2019)
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer
Yi Qin et al.
CELL PROLIFERATION (2019)
The roles of glucose metabolic reprogramming in chemo- and radio-resistance
Jinguan Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer
Debora Kristina Alves-Fernandes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways
Yehua Shen et al.
ONCOTARGETS AND THERAPY (2019)
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
Eileen M. O'Reilly et al.
JAMA ONCOLOGY (2019)
P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer
X. P. Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers
Shili Xu et al.
CANCER RESEARCH (2019)
Chemoresistance in Pancreatic Cancer
Siyuan Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
Monish Ram Makena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer
Kun Fan et al.
CANCER MEDICINE (2019)
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer
Goran Hamid Mohammad et al.
CANCERS (2019)
PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer
Xin Jin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis
Li-Peng Hu et al.
CLINICAL CANCER RESEARCH (2019)
RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer
Xiaomeng Zhang et al.
CANCER CELL INTERNATIONAL (2019)
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
Tulasigeri M. Totiger et al.
MOLECULAR CANCER THERAPEUTICS (2019)
KRAS4A directly regulates hexokinase 1
Caroline R. Amendola et al.
NATURE (2019)
Baohuoside I Inhibits the Proliferation of Pancreatic Cancer Cells via mTOR/S6K1-Caspases/Bcl2/Bax Apoptotic Signaling
Fubiao Ni et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Phosphofructokinase-1 subunit composition and activity in the skeletal muscle, liver, and brain of dogs
Shuichiro Kanai et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2019)
AMPK Inhibition Suppresses the Malignant Phenotype of Pancreatic Cancer Cells in Part by Attenuating Aerobic Glycolysis
Mingyue Hu et al.
JOURNAL OF CANCER (2019)
FAM84B promotes prostate tumorigenesis through a network alteration
Yanzhi Jiang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Significance of Glucose Transporter Type 1 (GLUT-1) Expression in the Therapeutic Strategy for Pancreatic Ductal Adenocarcinoma
Hiroshi Kurahara et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
ROS mediated EGFR/MEK/ERK/HIF-1α Loop Regulates Glucose metabolism in pancreatic cancer
Gang Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Non-coding RNAs in the reprogramming of glucose metabolism in cancer
Ram C. Shankaraiah et al.
CANCER LETTERS (2018)
Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury
Sang-Bing Ong et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
The role of TGF-beta/SMAD4 signaling in cancer
Ming Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
HIPK2-Mediated Transcriptional Control of NMDA Receptor Subunit Expression Regulates Neuronal Survival and Cell Death
Yulei Shang et al.
JOURNAL OF NEUROSCIENCE (2018)
TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer
Jinfeng Xiang et al.
CELL DEATH & DISEASE (2018)
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
Gustav van Niekerk et al.
CELLULAR ONCOLOGY (2018)
Dihydroartemisinin induces apoptosis and downregulates glucose metabolism in JF-305 pancreatic cancer cells
Wenhe Zhu et al.
RSC ADVANCES (2018)
Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States
Dongya Jia et al.
CELLS (2018)
Long noncoding RNAs: regulation, function and cancer
Aras Rafiee et al.
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 34, ISSUE 2 (2018)
Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α
Bin Yan et al.
EXPERIMENTAL CELL RESEARCH (2018)
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
Nina M. S. Gustafsson et al.
NATURE COMMUNICATIONS (2018)
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity
Giovanna Butera et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
The therapeutic potential of RNA regulation in neurological disorders
Jolien Roovers et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
Mengyu Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Unique pattern of neutrophil migration and function during tumor progression
Sima Patel et al.
NATURE IMMUNOLOGY (2018)
miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism
De-Hai Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
KrasG12D-LOH promotes malignant biological behavior and energy metabolism of pancreatic ductal adenocarcinoma cells through the mTOR signaling pathway
X. Shin et al.
NEOPLASMA (2018)
Cancer metabolism: New insights into classic characteristics
Yasumasa Kato et al.
JAPANESE DENTAL SCIENCE REVIEW (2018)
Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3′ splice sites within RNA secondary structures
A. K. Kesarwani et al.
ONCOGENE (2017)
Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer
Marco Sciacovelli et al.
FEBS JOURNAL (2017)
Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice
Shu-Heng Jiang et al.
GASTROENTEROLOGY (2017)
A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism
Wensheng Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
Hengqiang Zhao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport
Arvindhan Nagarajan et al.
MOLECULAR CELL (2017)
HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cells
Xin-gang Cui et al.
ONCOTARGET (2017)
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
Nirakar Rajbhandari et al.
CELL REPORTS (2017)
Pancreatic Cancer Chemoresistance to Gemcitabine
Manoj Amrutkar et al.
CANCERS (2017)
Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Safieh Ebrahimi et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Cancer metabolism: the volatile signature of glycolysis-in vitro model in lung cancer cells
Tali Feinberg et al.
JOURNAL OF BREATH RESEARCH (2017)
MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer
Venugopal Gunda et al.
CLINICAL CANCER RESEARCH (2017)
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Stephano S. Mello et al.
CANCER CELL (2017)
A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product
Maria V. Liberti et al.
CELL METABOLISM (2017)
Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction
Xin Jin et al.
CANCER RESEARCH (2017)
microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression
Dian-na Gu et al.
CANCER LETTERS (2017)
Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer
Xin Cai et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis
Jiefang Guo et al.
CANCER LETTERS (2017)
Mitochondrial mutations and metabolic adaptation in pancreatic cancer
Rae-Anne Hardie et al.
CANCER & METABOLISM (2017)
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer
Christopher J. Habrook et al.
CANCER CELL (2017)
PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma
Chenggang Li et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies
E. Hessmann et al.
ONCOGENE (2016)
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest
Michela Capello et al.
ONCOTARGET (2016)
More deaths from pancreatic cancer than breast cancer in the EU by 2017
J. Ferlay et al.
ACTA ONCOLOGICA (2016)
ALDOA functions as an oncogene in the highly metastatic pancreatic cancer
Shunrong Ji et al.
CANCER LETTERS (2016)
Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target
Geoffrey Grandjean et al.
CANCER RESEARCH (2016)
VEGF Promotes Glycolysis in Pancreatic Cancer via HIF1 alpha Up-Regulation
S. Shi et al.
CURRENT MOLECULAR MEDICINE (2016)
ALDH1A3, a metabolic target for cancer diagnosis and therapy
Jiang-Jie Duan et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka et al.
LANCET (2016)
Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment
Carly C. Barron et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation
Ninel Azoitei et al.
MOLECULAR CANCER (2016)
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Caroline Wigerup et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
Goran Hamid Mohammad et al.
PLOS ONE (2016)
Glucose metabolism in gastric cancer: The cutting-edge
Lian-Wen Yuan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
Samar Alsafadi et al.
NATURE COMMUNICATIONS (2016)
Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma
Hweixian Leong Penny et al.
ONCOIMMUNOLOGY (2016)
Regulation of glucose metabolism from a liver-centric perspective
Hye-Sook Han et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
REGγ regulates ERα degradation via ubiquitin-proteasome pathway in breast cancer
Fan Chai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma
Meng Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator
Brandon Faubert et al.
CANCER LETTERS (2015)
Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function
N. V. Rajeshkumar et al.
CANCER RESEARCH (2015)
L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation
Waldemar Wagner et al.
CELL COMMUNICATION AND SIGNALING (2015)
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer
Shunrong Ji et al.
CELL RESEARCH (2015)
A phase I, dose-escalation, multicenter study of ACT-PFK-158, 2HCl in patients with advanced solid malignancies explores a first-in-human inhibitor of glycolysis
Rebecca Ann Redman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
Tian-Lin He et al.
MEDICAL ONCOLOGY (2015)
The Effect of Silencing HIF-1α Gene in BxPC-3 Cell Line on Glycolysis-Related Gene Expression, Cell Growth, Invasion, and Apoptosis
Yi Jiang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Dysregulated metabolism contributes to oncogenesis
Matthew D. Hirschey et al.
SEMINARS IN CANCER BIOLOGY (2015)
MYC and metabolism on the path to cancer
Annie L. Hsieh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts
Joffrey Pelletier et al.
ONCOTARGET (2015)
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
Surendra K. Shukla et al.
ONCOTARGET (2015)
Endothelial PFKFB3 Plays a Critical Role in Angiogenesis
Yiming Xu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia
M. Maftouh et al.
BRITISH JOURNAL OF CANCER (2014)
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
Woondong Jeong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process
Yi Qin et al.
CANCER LETTERS (2014)
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
Julius Chapiro et al.
CLINICAL CANCER RESEARCH (2014)
Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis
Wantong Yao et al.
MOLECULAR CANCER (2014)
The structural basis for mTOR function
Domagoj Baretic et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
SIRT1 and other sirtuins in metabolism
Hung-Chun Chang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
Oleksandr H. Minchenko et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma
C. D. Hudson et al.
CELL DEATH & DISEASE (2014)
TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer
W. Xu et al.
CELL DEATH & DISEASE (2014)
Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration
Zhiwen Liu et al.
CANCER BIOLOGY & THERAPY (2013)
AMPK: A Contextual Oncogene or Tumor Suppressor?
Jiyong Liang et al.
CANCER RESEARCH (2013)
The Multifaceted Activities of AMPK in Tumor Progression-Why the One Size Fits All Definition Does Not Fit at All?
Marcelo G. Bonini et al.
IUBMB LIFE (2013)
Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
Zaheed Husain et al.
JOURNAL OF IMMUNOLOGY (2013)
mTOR: on target for novel therapeutic strategies in the nervous system
Kenneth Maiese et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells
Yefei Rong et al.
TUMOR BIOLOGY (2013)
Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus
Ling Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Tumour-associated mutant p53 drives the Warburg effect
Cen Zhang et al.
NATURE COMMUNICATIONS (2013)
SIRT3 Is a Mitochondrial Tumor Suppressor: A Scientific Tale That Connects Aberrant Cellular ROS, the Warburg Effect, and Carcinogenesis
Marcia C. Haigis et al.
CANCER RESEARCH (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression
Kotaro Miyake et al.
EXPERIMENTAL CELL RESEARCH (2012)
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation
Sucheta Telang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
Nina V. Chaika et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation
Carlotta Granchi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka et al.
NATURE (2011)
GLUT-1 Expression in Pancreatic Neoplasia Implications in Pathogenesis, Diagnosis, and Prognosis
Olca Basturk et al.
PANCREAS (2011)
Prolyl 4-hydroxylase
Kelly L. Gorres et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Chi V. Dang et al.
CLINICAL CANCER RESEARCH (2009)
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Abdullah Yalcin et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
Paola Cappello et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
TOR complex 2: a signaling pathway of its own
Nadine Cybulski et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
Tsuneo Ikenoue et al.
EMBO JOURNAL (2008)
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Lee M. Greenberger et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells
Laleh G. Melstrom et al.
PANCREAS (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
ARHGAP4 is a novel RhoGAP that mediates inhibition of cell motility and axon outgrowth
D. L. Vogt et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma
TL Hwang et al.
PROTEOMICS (2006)
HMG proteins: dynamic players in gene regulation and differentiation
ME Bianchi et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
被撤回的出版物: Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity (Retracted article. See vol. 173, pg. 1108, 2023)
H Ito et al.
SURGERY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
The tripartite motif family identifies cell compartments
A Reymond et al.
EMBO JOURNAL (2001)
Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia
CH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
